Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Biora Therapeutics ( (BIOR) ) has issued an announcement.
Biora Therapeutics faced potential delisting from Nasdaq due to failing to meet the market value of listed securities (MVLS) and market value of publicly held shares (MVPHS) requirements. Despite receiving an extension to comply with Nasdaq rules, the company must demonstrate compliance by December 9, 2024, to maintain its listing. At a special meeting, stockholders approved key proposals related to issuing common stock and amending the company’s 2018 Plan, reflecting efforts to address compliance challenges.
See more data about BIOR stock on TipRanks’ Stock Analysis page.
